ACTUATE THERAPEUTICS, INC. (ACTU) Stock Profile — Insider Trades & Financials

Net Income-$4.6M

EPS$-0.88

Market Cap$50.3M

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

Daniel Schmitt

CEO & Executive Director

Company profile for Actuate Therapeutics, Inc. (ACTU) stock, with a description, list of executives, contact details and other key facts.

Founded: 2015
Employees: 1
Headquarters: FORT WORTH, TX, United States
Website: actuatetherapeutics.com

Peer ComparisonRevenue ($B)

▾

⚡

Core Efficiency

ROE?

-57.47%

ROA?

-32.45%

D/E Ratio?

0.77

📊

Profitability Ratios

Current Ratio?

2.39

Loading comparison...

Earnings Calendar

Filing history and next expected filing date

Next Expected Filing

Sep 12, 2026 (in 158 days)

Annual Report (10-K) — Based on filing pattern

Sep 12, 2026

Predicted10-K

Mar 26, 2026

10-KQ4 20251d after period end

Mar 26, 2026

10-KFY 202585d after period end

Nov 13, 2025

10-QQ3 20251d after period end

Aug 14, 2025

10-QQ2 20251d after period end

May 15, 2025

10-QQ1 20251d after period end

Mar 13, 2025

10-KQ4 20243d after period end

Mar 13, 2025

10-KFY 202572d after period end

Nov 13, 2024

10-QQ3 20242d after period end

Loading company sections...

ACTUATE THERAPEUTICS, INC.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Earnings Calendar

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness